Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background: Non-alcoholic liver steatosis (NAS) results from an imbalance between hepatic lipid storage, disposal, and partitioning. A multifactorial diet high in fiber, monounsaturated fatty acids (MUFAs), n-6 and n-3 polyunsaturated fatty acids (PUFAs), polyphenols, and vitamins D, E, and C reduces NAS in people with type 2 diabetes (T2D) by 40% compared to a MUFA-rich diet. We evaluated whether dietary effects on NAS are mediated by changes in hepatic de novo lipogenesis (DNL), stearoyl-CoA desaturase (SCD1) activity, and/or β-oxidation. Methods: According to a randomized parallel group study design, 37 individuals with T2D completed an 8-week isocaloric intervention with a MUFA diet (n = 20) or multifactorial diet (n = 17). Before and after the intervention, liver fat content was evaluated by proton magnetic resonance spectroscopy, serum triglyceride fatty acid concentrations measured by gas chromatography, plasma β-hydroxybutyrate by enzymatic method, and DNL and SCD-1 activity assessed by calculating the palmitic acid/linoleic acid (C16:0/C18:2 n6) and palmitoleic acid/palmitic acid (C16:1/C16:0) ratios, respectively. Results: Compared to baseline, mean ± SD DNL significantly decreased after the multifactorial diet (2.2 ± 0.8 vs. 1.5 ± 0.5, p = 0.0001) but did not change after the MUFA diet (1.9 ± 1.1 vs. 1.9 ± 0.9, p = 0.949), with a significant difference between the two interventions (p = 0.004). The mean SCD-1 activity also decreased after the multifactorial diet (0.13 ± 0.05 vs. 0.10 ± 0.03; p = 0.001), but with no significant difference between interventions (p = 0.205). Fasting plasma β-hydroxybutyrate concentrations did not change significantly after the MUFA or multifactorial diet. Changes in the DNL index significantly and positively correlated with changes in liver fat (r = 0.426; p = 0.009). Conclusions: A diet rich in multiple beneficial dietary components (fiber, polyphenols, MUFAs, PUFAs, and other antioxidants) compared to a diet rich only in MUFAs further reduces liver fat accumulation through the inhibition of DNL. Registered under ClinicalTrials.gov no. NCT03380416.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Costabile et al.51 showed that isoenergetic substitution of SFAs with unsaturated fatty acids reduced IHTG.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated using the following formula: fasting glucose (mg/dL) × fasting insulin (μU/mL)/405 [14].”
MethodToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235 · cited 8×
“In line with these findings, other studies showed that patients with NAFLD are characterized by increased MUFA and decreased linoleic acid in plasma and their fatty acid profile is linked to an upregulated lipogenesis [25,26].”
BackgroundInfluentialProgression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747 · cited 1×
“NAFLD is tied to cardiovascular disease and risk of type 2 diabetes (T2D) onset [2].”
BackgroundLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“DNL accounts for up to 30% of triglyceride production in people with NAFLD and insulin resistance, but accounts for only 5% in healthy people [21].”
BackgroundPolyphenols and Human Health: The Role of Bioavailability
Di Lorenzo, C., Colombo, F., Biella, S., Stockley, C., & Restani, P. (2021) · Nutrients · doi:10.3390/nu13010273 · Cited by 903 · cited 1×
“Furthermore, the latter show a low bioavailability, and therefore it is difficult to define their real contribution in the context of the overall diet [34].”
BackgroundBugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770 · cited 1×
“Individuals with NAFLD may have lower [29], similar [30], or higher [31] plasma β-hydroxybutyrate concentrations than individuals without NAFLD.”
BackgroundThe plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655 · cited 1×
“In line with these findings, other studies showed that patients with NAFLD are characterized by increased MUFA and decreased linoleic acid in plasma and their fatty acid profile is linked to an upregulated lipogenesis [25,26].”
ResultBjermo, H., Iggman, D., Kullberg, J., Dahlman, I., Johansson, L., Persson, L., Berglund, J., Pulkki, K., Basu, S., Uusitupa, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.030114 · Cited by 490 · cited 10×
“Weight loss and qualitative dietary changes, mainly consisting of replacing saturated fatty acids with monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs), and simple sugars with complex carbohydrates and fiber, or increasing dietary components with antioxidant properties, are the dietary maneu…”
ResultInfluentialMardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 453 · cited 9×
“In line with these findings, other studies showed that patients with NAFLD are characterized by increased MUFA and decreased linoleic acid in plasma and their fatty acid profile is linked to an upregulated lipogenesis [25,26].”
MethodInfluential
Cited by
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
“359 Dietary polyphenols, such as iso fl avone, lignans, and their metabolites derived from intestinal microorganisms can cross the intestinal barrier and the BBB and prevent neuroin fl ammatory stimulation.”
BackgroundLipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
Alizadeh, J., Kavoosi, M., Singh, N., Lorzadeh, S., Ravandi, A., Kidane, B., Ahmed, N., Mraiche, F., Mowat, M. R. A., & Ghavami, S. (2023) · Cancers · doi:10.3390/cancers15082195 · Cited by 53
“In fact, ULK1 inhibition reduces SCD1 expression in liver cells, increasing the SFA/MUFA ratio and, subsequently, leading to cell death [411].”
BackgroundLiu, Y., Fei, Z., Zhao, H., Song, J.-G., Song, M. J., Zhu, J., Wang, Y., Hoi, M. P. M., Lin, L., & Zhang, Q. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.047 · Cited by 33
Li, H., Hou, Y., Xin, W., Ding, L., Yang, Y., Zhang, Y., Wu, W., Wang, Z., & Ding, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107647 · Cited by 28
Metadata
- Authors
- Costabile, G., Della Pepa, G., Salamone, D., Luongo, D., Naviglio, D., Brancato, V., Cavaliere, C., Salvatore, M., Cipriano, P., Vitale, M., Corrado, A., Rivellese, A., Annuzzi, G., & Bozzetto, L.
- Affiliations
- Federico II University Hospital (IT)
- Department of Clinical Medicine and Surgery, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy
- Institute of Biostructure and Bioimaging (IT)
- University of Naples Federico II (IT)
- IRCCS Synlab SDN, Via Emanuele Gianturco, 113, 80143 Naples, Italy
- Corresponding author
- Annuzzi, Giovanni
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-05-23
- Volume
- 14
- Issue
- 10
- Pages
- 2178
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9143579
- OpenAlex
- W4282923308
- Cited by
- 27
- References
- 35
- Citations by year
- 2025: 6 · 2024: 10 · 2023: 10 · 2022: 1
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Department of Clinical Medicine and Surgery of the Federico II University Hospital
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, hepatic steatosis, de novo lipogenesis, stearoyl-CoA desaturase 1, monounsaturated fatty acids, type 2 diabetes, isocaloric diet, fatty acid oxidation, beta-hydroxybutyrate, hepatic lipid metabolism, palmitoleic acid, linoleic acid
- MeSH terms
- Diabetes Mellitus, Type 2, Diet, Humans, Stearoyl-CoA Desaturase, Palmitic Acid, 3-Hydroxybutyric Acid, Lipogenesis, Polyphenols, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial. https://app.cochat.ai/papers/10.3390/nu14102178
- The paper
- Costabile, G., Della Pepa, G., Salamone, D., Luongo, D., Naviglio, D., Brancato, V., Cavaliere, C., Salvatore, M., Cipriano, P., Vitale, M., Corrado, A., Rivellese, A., Annuzzi, G., & Bozzetto, L. (2022). Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial. Nutrients. https://doi.org/10.3390/nu14102178
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.